Titre : Tuberculose ultrarésistante aux médicaments

Tuberculose ultrarésistante aux médicaments : Questions médicales fréquentes

Termes MeSH sélectionnés :

Problem Solving
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Tuberculose ultrarésistante aux médicaments : Questions médicales les plus fréquentes", "headline": "Tuberculose ultrarésistante aux médicaments : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Tuberculose ultrarésistante aux médicaments : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Tuberculose ultrarésistante aux médicaments" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Tuberculose multirésistante", "url": "https://questionsmedicales.fr/mesh/D018088", "about": { "@type": "MedicalCondition", "name": "Tuberculose multirésistante", "code": { "@type": "MedicalCode", "code": "D018088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.150.252.410.040.552.846.775" } } }, "about": { "@type": "MedicalCondition", "name": "Tuberculose ultrarésistante aux médicaments", "alternateName": "Extensively Drug-Resistant Tuberculosis", "code": { "@type": "MedicalCode", "code": "D054908", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Peize Zhang", "url": "https://questionsmedicales.fr/author/Peize%20Zhang", "affiliation": { "@type": "Organization", "name": "Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China." } }, { "@type": "Person", "name": "Guofang Deng", "url": "https://questionsmedicales.fr/author/Guofang%20Deng", "affiliation": { "@type": "Organization", "name": "Pulmonary Medicine and Tuberculosis, The Third People's Hospital of Shenzhen, The National Clinical Research Center for Infectious Diseases, Shenzhen, China." } }, { "@type": "Person", "name": "Nam Xuan Vo", "url": "https://questionsmedicales.fr/author/Nam%20Xuan%20Vo", "affiliation": { "@type": "Organization", "name": "Graduate Program in Social, Economic and Administrative Pharmacy, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok 10400, Thailand." } }, { "@type": "Person", "name": "Trung Quang Vo", "url": "https://questionsmedicales.fr/author/Trung%20Quang%20Vo", "affiliation": { "@type": "Organization", "name": "Department of Economic and Administrative Pharmacy (EAP), Faculty of Pharmacy, Pham Ngoc Thach University of Medicine, Ho Chi Minh City 700000, Vietnam." } }, { "@type": "Person", "name": "Getu Diriba", "url": "https://questionsmedicales.fr/author/Getu%20Diriba", "affiliation": { "@type": "Organization", "name": "Ethiopian Public Health Institute, Addis Ababa, Ethiopia. Electronic address: getud2020@gmail.com." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Cognitive control of invalid predominant ideas in insight-like problem solving.", "datePublished": "2022-06-25", "url": "https://questionsmedicales.fr/article/35751854", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/psyp.14133" } }, { "@type": "ScholarlyArticle", "name": "Self-Regulated Learning and Working Memory Determine Problem-Solving Accuracy in Math.", "datePublished": "2022-09-26", "url": "https://questionsmedicales.fr/article/36155128", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1017/SJP.2022.19" } }, { "@type": "ScholarlyArticle", "name": "Verbal problem-solving in agenesis of the corpus callosum: Analysis using semantic similarity.", "datePublished": "2023-03-02", "url": "https://questionsmedicales.fr/article/36862453", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1037/neu0000894" } }, { "@type": "ScholarlyArticle", "name": "The underlying neural bases of the reversal error while solving algebraic word problems.", "datePublished": "2022-12-15", "url": "https://questionsmedicales.fr/article/36522380", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-25442-5" } }, { "@type": "ScholarlyArticle", "name": "Structural and metabolic brain correlates of arithmetic word-problem solving in Huntington's disease.", "datePublished": "2023-02-19", "url": "https://questionsmedicales.fr/article/36807154", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jnr.25174" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Infections bactériennes et mycoses", "item": "https://questionsmedicales.fr/mesh/D001423" }, { "@type": "ListItem", "position": 4, "name": "Infections bactériennes", "item": "https://questionsmedicales.fr/mesh/D001424" }, { "@type": "ListItem", "position": 5, "name": "Infections bactériennes à Gram positif", "item": "https://questionsmedicales.fr/mesh/D016908" }, { "@type": "ListItem", "position": 6, "name": "Infections à Actinomycetales", "item": "https://questionsmedicales.fr/mesh/D000193" }, { "@type": "ListItem", "position": 7, "name": "Infections à Mycobacterium", "item": "https://questionsmedicales.fr/mesh/D009164" }, { "@type": "ListItem", "position": 8, "name": "Tuberculose", "item": "https://questionsmedicales.fr/mesh/D014376" }, { "@type": "ListItem", "position": 9, "name": "Tuberculose multirésistante", "item": "https://questionsmedicales.fr/mesh/D018088" }, { "@type": "ListItem", "position": 10, "name": "Tuberculose ultrarésistante aux médicaments", "item": "https://questionsmedicales.fr/mesh/D054908" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Tuberculose ultrarésistante aux médicaments - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Tuberculose ultrarésistante aux médicaments", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Tuberculose ultrarésistante aux médicaments", "description": "Comment diagnostiquer la XDR-TB ?\nQuels tests sont utilisés pour la XDR-TB ?\nQuels symptômes indiquent une XDR-TB ?\nLa radiographie est-elle utile pour la XDR-TB ?\nPeut-on détecter la XDR-TB par un test rapide ?", "url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Problem+Solving&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Tuberculose ultrarésistante aux médicaments", "description": "Quels sont les symptômes principaux de la XDR-TB ?\nLa douleur thoracique est-elle un symptôme ?\nLes sueurs nocturnes sont-elles fréquentes ?\nLa fatigue est-elle un symptôme de la XDR-TB ?\nPeut-on avoir des symptômes gastro-intestinaux ?", "url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Problem+Solving&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Tuberculose ultrarésistante aux médicaments", "description": "Comment prévenir la XDR-TB ?\nLe port de masques est-il recommandé ?\nLa vaccination BCG est-elle efficace contre la XDR-TB ?\nLes contacts doivent-ils être testés ?\nLes soins de santé doivent-ils être formés ?", "url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Problem+Solving&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Tuberculose ultrarésistante aux médicaments", "description": "Quel est le traitement standard pour la XDR-TB ?\nLes médicaments de première ligne sont-ils efficaces ?\nY a-t-il des effets secondaires aux traitements ?\nLa chirurgie est-elle une option de traitement ?\nLes traitements sont-ils coûteux ?", "url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Problem+Solving&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Tuberculose ultrarésistante aux médicaments", "description": "Quelles sont les complications de la XDR-TB ?\nLa XDR-TB peut-elle causer des infections secondaires ?\nY a-t-il un risque de transmission accrue ?\nLes complications affectent-elles la qualité de vie ?\nLa résistance aux médicaments complique-t-elle le traitement ?", "url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Problem+Solving&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Tuberculose ultrarésistante aux médicaments", "description": "Quels sont les principaux facteurs de risque ?\nLe tabagisme augmente-t-il le risque ?\nLes personnes âgées sont-elles plus à risque ?\nLes conditions de vie affectent-elles le risque ?\nLes travailleurs de la santé sont-ils à risque ?", "url": "https://questionsmedicales.fr/mesh/D054908?mesh_terms=Problem+Solving&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la XDR-TB ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic se fait par culture bactérienne et tests de sensibilité aux antibiotiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour la XDR-TB ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests incluent la culture, le test de sensibilité et la PCR pour Mycobacterium tuberculosis." } }, { "@type": "Question", "name": "Quels symptômes indiquent une XDR-TB ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent toux persistante, fièvre, sueurs nocturnes et perte de poids." } }, { "@type": "Question", "name": "La radiographie est-elle utile pour la XDR-TB ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la radiographie thoracique peut montrer des lésions pulmonaires caractéristiques." } }, { "@type": "Question", "name": "Peut-on détecter la XDR-TB par un test rapide ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des tests rapides comme GeneXpert peuvent détecter la résistance aux médicaments." } }, { "@type": "Question", "name": "Quels sont les symptômes principaux de la XDR-TB ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes principaux sont toux, fièvre, fatigue, et perte d'appétit." } }, { "@type": "Question", "name": "La douleur thoracique est-elle un symptôme ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la douleur thoracique peut survenir en raison de l'infection pulmonaire." } }, { "@type": "Question", "name": "Les sueurs nocturnes sont-elles fréquentes ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les sueurs nocturnes sont un symptôme courant de la tuberculose avancée." } }, { "@type": "Question", "name": "La fatigue est-elle un symptôme de la XDR-TB ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue persistante est souvent rapportée par les patients atteints de XDR-TB." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes gastro-intestinaux ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme la diarrhée peuvent survenir, surtout avec des traitements prolongés." } }, { "@type": "Question", "name": "Comment prévenir la XDR-TB ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention inclut le dépistage précoce, l'isolement des cas et la vaccination BCG." } }, { "@type": "Question", "name": "Le port de masques est-il recommandé ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le port de masques peut réduire le risque de transmission dans les zones à risque." } }, { "@type": "Question", "name": "La vaccination BCG est-elle efficace contre la XDR-TB ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination BCG offre une protection limitée contre la XDR-TB, mais reste recommandée." } }, { "@type": "Question", "name": "Les contacts doivent-ils être testés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les contacts des patients doivent être testés régulièrement pour détecter la tuberculose." } }, { "@type": "Question", "name": "Les soins de santé doivent-ils être formés ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la formation des professionnels de santé est cruciale pour gérer la XDR-TB efficacement." } }, { "@type": "Question", "name": "Quel est le traitement standard pour la XDR-TB ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement standard inclut des antibiotiques spécifiques pendant au moins 18 mois." } }, { "@type": "Question", "name": "Les médicaments de première ligne sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les médicaments de première ligne ne sont généralement pas efficaces contre la XDR-TB." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent causer des effets secondaires comme nausées et hépatotoxicité." } }, { "@type": "Question", "name": "La chirurgie est-elle une option de traitement ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être envisagée pour retirer des lésions pulmonaires dans certains cas." } }, { "@type": "Question", "name": "Les traitements sont-ils coûteux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements de la XDR-TB peuvent être très coûteux et nécessitent un suivi régulier." } }, { "@type": "Question", "name": "Quelles sont les complications de la XDR-TB ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent l'insuffisance respiratoire, la septicémie et la mort." } }, { "@type": "Question", "name": "La XDR-TB peut-elle causer des infections secondaires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les patients peuvent développer des infections secondaires en raison d'une immunité affaiblie." } }, { "@type": "Question", "name": "Y a-t-il un risque de transmission accrue ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la XDR-TB augmente le risque de transmission dans les communautés vulnérables." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent gravement affecter la qualité de vie des patients." } }, { "@type": "Question", "name": "La résistance aux médicaments complique-t-elle le traitement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la résistance aux médicaments rend le traitement plus long et plus complexe." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le VIH, la malnutrition, et l'exposition à des cas de tuberculose." } }, { "@type": "Question", "name": "Le tabagisme augmente-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme est un facteur de risque connu pour la tuberculose et ses formes résistantes." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru en raison d'un système immunitaire affaibli." } }, { "@type": "Question", "name": "Les conditions de vie affectent-elles le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les conditions de vie surpeuplées et insalubres augmentent le risque de XDR-TB." } }, { "@type": "Question", "name": "Les travailleurs de la santé sont-ils à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les travailleurs de la santé sont exposés à un risque accru de contracter la XDR-TB." } } ] } ] }

Sources (7765 au total)

Verbal problem-solving in agenesis of the corpus callosum: Analysis using semantic similarity.

Previous studies demonstrated that individuals with agenesis of the corpus callosum (AgCC) experience difficulties in novel and complex problem-solving. The present study investigated verbal problem-s... Capacity for semantic inference was tested in 25 individuals with AgCC and normal-range intelligence compared to 29 neurotypical controls. The Word Context Test (WCT) of Delis-Kaplan Executive Functio... With respect to the typical WCT scores, persons with AgCC had fewer total consecutive correct responses. In addition, semantic similarity to the correct word was significantly lower overall in persons... These findings indicated that individuals with AgCC who have intelligence in the normal range are less able at the WCT taking all trials into account, although they often solve the problem eventually....

The RESCUE problem solving intervention for stroke caregivers: A mixed-methods pilot study.

Stroke caregivers face many challenges after a family member experiences stroke. Because caregivers play such a crucial role in health care, there is a need for more interventions in web-based formats... A one-group, pretest-posttest design with a mixed-methods approach was used. Qualitative data supplemented the quantitative findings. Community-dwelling caregivers of stroke patients were recruited fr... Ninety-three caregivers were recruited; 72 caregivers completed the intervention and 21 withdrew (77% completion rate). From pre- to posttest, caregiver depression (... The intervention was feasible to implement and acceptable to caregivers. This intervention shows promise for fulfilling a need for more web-based interventions that focus on skills building and psycho...

Metacognitive prompts and numerical ordinality in solving word problems: An eye-tracking study.

The ability to translate concrete manipulatives into abstract mathematical formulas can aid in the solving of mathematical word problems among students, and metacognitive prompts play a significant ro... Based on the concept of semantic congruence, we explored the effects of metacognitive prompts and numerical ordinality on information searching and cognitive processing, throughout the process of solv... Participants included 73 primary school students (38 boys and 35 girls) with normal or corrected visual acuity.... This study was based on a 2 (prompt information: no-prompt, metacognitive-prompt) × 2 (number attribute: cardinal number, ordinal number) mixed experimental design. We analysed multiple eye-movement i... When solving both types of problems, pupil sizes were significantly smaller under the metacognitive-prompt condition compared with the no-prompt condition, and shorter dwell time for specific sentence... The results indicate that for Chinese upper-grade primary school students, cognitive load was lower in the metacognitive prompting condition and when solving cardinal problems, and higher when solving...

Social problem-solving attitudes and performance as a function of differences in trait and state worry.

This study investigated problem-solving attitudes and state-dependent, performance-based problem-solving abilities of individuals with high trait worry as compared to those low in trait worry. Seconda... A 2 (group: high worry, n = 68, vs. low worry, n = 66) X 2 (induction type: worry vs. neutral mentation) factorial design was employed to investigate the differential effects of state worry, and neutr... Previous findings that individuals with high trait worry endorse greater tendencies to self-report unconstructive problem-solving attitudes were replicated. Contrary to predictions, there were no sign... Study did not directly assess problem-solving for personal problems.... Disparities in self-appraisal may account for lack of worry-related performance differences. Findings suggest that when employing problem-solving interventions with a high worry population, emphasis s...